Even new antimicrobial susceptibility testing technologies themselves may need some specialized consumables that will further contribute to increased market growth. In the case of molecular ...

Even new antimicrobial susceptibility testing technologies themselves may need some specialized consumables that will further contribute to increased market growth. In the case of molecular methods of ...

Moreover, the presence of dPCR in molecular/genetic field and diagnostics is supposed to drive the growth of this market ... and B in approximate 30 minutes. MarketsandMarkets™ has been ...

6, 2024 /PRNewswire/ -- The global antimicrobial susceptibility testing market is projected ... In such respects, both traditional and molecular clinical diagnostics systems provide very ...

Delray Beach, FL, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The global biosimulation market growth forecasted to transform from USD 4.24 billion in 2024 to USD 9.18 billion by 2029, driven by a CAGR of 16 ...

22, 2024 (GLOBE NEWSWIRE) -- The global biosimulation market growth ... ranging from general molecular modeling programs to a full-featured drug design software suite using ligand-and structure-based ...

In 2023, the US FDA approved 55 novel drug therapies, while as of 2024, 36 novel drug therapies have been approved so far, reflecting the scope of the segment and its substantial large market share.